Skip to Main Content

Nicotine Receptor Changes During Smoking Abstinence Revealed by PET

Publication Title: Multiple sources of β2*-nicotinic acetylcholine receptor binding are differentially affected during tobacco smoking abstinence as revealed by Independent Component Analysis of [18F]Flubatine PET images

Summary

Question
This study explored how tobacco smoking affects the binding of β2*-nicotinic acetylcholine receptors (β2*-nAChRs) in the brain. Using advanced imaging techniques, the researchers aimed to identify and compare distinct subtypes of β2*-nAChRs in individuals who had recently stopped smoking and those who never smoked.
Why it Matters
Smoking is a leading cause of preventable death, driven largely by nicotine's effects on β2*-nAChRs, which are proteins in the brain involved in nicotine addiction and withdrawal. Understanding how these receptors behave during smoking abstinence could improve treatments to help people quit smoking by targeting specific receptor subtypes that influence addiction and withdrawal symptoms.
Methods
The researchers used positron emission tomography (PET), a type of brain imaging, with a radiotracer called [18F]Flubatine that binds specifically to β2*-nAChRs. They analyzed data from 26 abstinent smokers and 20 non-smokers to identify distinct receptor subtypes using a statistical method called independent component analysis (ICA). They also validated these findings through nicotine challenges and post-mortem brain tissue studies.
Key Findings
Three distinct receptor subtypes were identified. Two subtypes, primarily found in the thalamus and midbrain, showed reduced binding in abstinent smokers compared to non-smokers. A third subtype, linked to α3β2*-nAChRs and found in the cerebellum, had increased binding in abstinent smokers. This increase was associated with heavier smoking and greater nicotine dependence, suggesting that different receptor subtypes respond uniquely to nicotine exposure and abstinence.
Implications
The findings suggest that α3β2*-nAChRs in the cerebellum may play a role in nicotine dependence and withdrawal. These receptors could be a novel target for developing treatments to alleviate withdrawal symptoms and support smoking cessation. Additionally, the study provides new insights into how chronic smoking alters brain receptor subtypes, which could influence broader addiction research.
Next Steps
Future research should confirm these findings in larger, independent samples and investigate whether targeting specific receptor subtypes, such as α3β2*-nAChRs, can improve smoking cessation therapies. The researchers also suggest exploring the role of these receptors in other conditions influenced by nicotine, such as cognitive deficits during withdrawal.
Funding Information
This research was supported by R01 DA038832, R37 DA014241, P30 AG066508, and U54 DA036151 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Yale University also provided funding and support for this research.

Full Citation

Raval N, Calakos K, Zheng M, Huttner A, Esterlis I, Huang H, Calhoun V, Picciotto M, Cosgrove K, Hillmer A. Multiple sources of β2*-nicotinic acetylcholine receptor binding are differentially affected during tobacco smoking abstinence as revealed by Independent Component Analysis of [18F]Flubatine PET images. Neuropsychopharmacology 2026, 1-10. PMID: 41559453, DOI: 10.1038/s41386-025-02311-z.
This AI-assisted summary has been reviewed and approved by at least one of the study's authors to ensure it accurately reflects the research.

Authors

  • Nakul Ravi Raval, PhD

    First Author
    Yale School of Medicine

    Associate Research Scientist in Psychiatry

  • Ansel Hillmer, PhD

    Last Author
    Yale School of Medicine

    Associate Professor Adjunct

Research Themes